National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings, 3903 [2013-00879]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 12 / Thursday, January 17, 2013 / Notices
Dated: January 13, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Dated: January 10, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–00885 Filed 1–16–13; 8:45 am]
[FR Doc. 2013–00879 Filed 1–16–13; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meetings
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
pmangrum on DSK3VPTVN1PROD with
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel P41 Site Visit M4
(2013/05).
Date: March 6–8, 2013.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree by Hilton Hotel
Tarrytown, 455 South Broadway, Tarrytown,
NY 10591.
Contact Person: Ruth Grossman, DDS,
Scientific Review Officer, National Institute
of Biomedical Imaging and, Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Room 960, Bethesda,
MD 20892, 301–496–8775,
grossmanrs@mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, P41 Site Visit M3
(2013/05).
Date: March 20–22, 2013.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Affinia Dumont, 150 E 34th
Street, New York, NY 10016.
Contact Person: Ruth Grossman, DDS,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Room 960, Bethesda,
MD 20892, 301–496–8775,
grossmanrs@mail.nih.gov.
VerDate Mar<15>2010
14:19 Jan 16, 2013
Jkt 229001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Diabetes and Digestive and Kidney
Diseases Advisory Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: February 13, 2013.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Digestive Diseases and Nutrition
Subcommittee.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
3903
Date: February 13, 2013.
Open: 1:00 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Diabetes, Endocrine and Metabolic
Diseases Subcommittee.
Date: February 13, 2013.
Open: 2:30 p.m. to 4:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Kidney, Urologic and Hematologic
Diseases Subcommittee.
Date: February 13, 2013.
Open: 1:00 p.m. to 3:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Closed: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive,
and Kidney Diseases, 6707 Democracy Blvd.
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuttles
E:\FR\FM\17JAN1.SGM
17JAN1
]]>Agencies
[Federal Register Volume 78, Number 12 (Thursday, January 17, 2013)]
[Notices]
[Page 3903]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00879]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel P41 Site Visit M4 (2013/05).
Date: March 6-8, 2013.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree by Hilton Hotel Tarrytown, 455 South Broadway,
Tarrytown, NY 10591.
Contact Person: Ruth Grossman, DDS, Scientific Review Officer,
National Institute of Biomedical Imaging and, Bioengineering,
National Institutes of Health, 6707 Democracy Boulevard, Room 960,
Bethesda, MD 20892, 301-496-8775, grossmanrs@mail.nih.gov.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel, P41 Site Visit M3 (2013/05).
Date: March 20-22, 2013.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Affinia Dumont, 150 E 34th Street, New York, NY
10016.
Contact Person: Ruth Grossman, DDS, Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Boulevard, Room 960,
Bethesda, MD 20892, 301-496-8775, grossmanrs@mail.nih.gov.
Dated: January 10, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-00879 Filed 1-16-13; 8:45 am]
BILLING CODE 4140-01-P
